Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
149.25B | 134.43B | 159.46B | 142.20B | 106.72B | 100.72B | Gross Profit |
43.10B | 38.04B | 46.40B | 40.89B | 28.77B | 26.14B | EBIT |
17.28B | 13.11B | 21.17B | 17.88B | 7.70B | 5.23B | EBITDA |
22.38B | 20.31B | 28.37B | 23.79B | 13.21B | 11.05B | Net Income Common Stockholders |
11.44B | 8.34B | 14.79B | 12.57B | 5.27B | 3.69B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
29.40B | 28.30B | 28.57B | 34.53B | 36.38B | 18.99B | Total Assets |
214.31B | 208.28B | 185.63B | 172.51B | 152.73B | 136.06B | Total Debt |
35.38B | 37.53B | 18.63B | 17.89B | 20.41B | 23.51B | Net Debt |
5.98B | 9.79B | -9.94B | -16.63B | -15.96B | 4.52B | Total Liabilities |
79.80B | 79.19B | 65.90B | 62.94B | 55.11B | 53.60B | Stockholders Equity |
134.51B | 129.10B | 119.73B | 109.57B | 97.50B | 82.36B |
Cash Flow | Free Cash Flow | ||||
0.00 | -12.99B | -702.00M | 4.12B | 14.56B | 13.17B | Operating Cash Flow |
0.00 | 7.60B | 11.05B | 12.35B | 17.52B | 17.25B | Investing Cash Flow |
0.00 | -20.23B | -12.79B | -8.54B | -2.79B | -4.55B | Financing Cash Flow |
0.00 | 13.05B | -5.74B | -6.26B | 2.42B | -6.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $17.58T | 28.76 | 10.50% | 1.10% | 0.56% | 5.32% | |
71 Outperform | $859.27B | 15.04 | 13.62% | 1.98% | -6.60% | 12.77% | |
68 Neutral | $365.55B | 28.46 | 1.72% | 4.17% | -0.38% | -65.61% | |
66 Neutral | ¥746.38B | 45.89 | 2.10% | 2.64% | -6.57% | -76.15% | |
64 Neutral | $4.39B | 11.81 | 5.17% | 249.38% | 3.98% | -12.17% | |
63 Neutral | ¥152.46B | 11.24 | 3.54% | 6.94% | 14.98% | ||
52 Neutral | ¥297.72B | 29.61 | 5.23% | -3.42% | -35.09% |